Etoposide
About
Therapy type: Chemotherapy
Therapy strategy: Topoisomerase inhibition
Mappings
NCI Thesaurus: Etoposide (coding:ncit:C491)
RxNorm: etoposide (coding:rxcui:4179, coding:omop:1350504)
SNOMED: Etoposide (coding:sctid:387316009, coding:omop:4306843)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | CD20 + | Diffuse Large B-Cell Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine | |
| EMA (1) | CD20 + | Non-Hodgkin Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine | |
| EMA (1) | CD20 + | Burkitt Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine | |
| EMA (1) | CD30 + | Hodgkin Lymphoma | Brentuximab vedotin, Cyclophosphamide, Dacarbazine, Dexamethasone, Doxorubicin, Etoposide |